MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENTMaterials Cooperative Research and Development Agreement • January 15th, 2016
This Materials Cooperative Research and Development Agreement (“M-CRADA”) has been adopted for use by the Institutes and Centers (“ICs”) of the National Institutes of Health (“NIH”) for transfers of essential research material(s) from collaborators (hereinafter “Collaborator Research Material”) not otherwise reasonably available for NIH research. It consists of a copy of the NIH Model M-CRADA, a Signature Page, a Contacts Page, and a Summary Page. The research plan (“Research Plan”) is attached as Appendix A and all changes to this model agreement are collected in Appendix B. Appendices A and B are incorporated herein by reference. This M-CRADA involves no exchange of personnel or of any resources other than as described in Appendix A. This M-CRADA is made under authority of the Federal Technology Transfer Act, 15 U.S.C. § 3710a, and is governed by its terms.
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT (MCRADA)Materials Cooperative Research and Development Agreement • April 13th, 2021
This Materials Cooperative Research and Development Agreement (“Materials CRADA”) has been adopted for use by the Environmental Protection Agency (“EPA”) for collaborations that will not exceed two years in term; will involve transfers of essential material (“Research Material”), but no other resources; and are unlikely to result in new intellectual property. Typical applications include short-term studies to: 1) test new reagents or research tools when such assessments require collaboration between provider and recipient institutions or 2) determine the feasibility, optimal study design, and/or resource requirements for a long-term study between the collaborating institutions. Collaborative research and development studies not meeting these criteria must be submitted for approval using the standard CRADA agreement.
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENTMaterials Cooperative Research and Development Agreement • February 21st, 2018
This Materials Cooperative Research and Development Agreement (“M-CRADA”) has been adopted for use by the Centers for Disease Control and Prevention (“CDC”) for transfers of essential research material(s) from collaborators (hereinafter “Collaborator Research Material”) not otherwise reasonably available for CDC research. It consists of a copy of the CDC Model M-CRADA, a Signature Page, a Contacts Page, and a Summary Page. The research plan (“Research Plan”) is attached as Appendix A and all changes to this model agreement are collected in Appendix B. Appendices A and B are incorporated herein by reference. This M-CRADA involves no exchange of personnel or of any resources other than as described in Appendix A. This M-CRADA is made under authority of the Federal Technology Transfer Act, 15 U.S.C. § 3710a, and is governed by its terms.
NATIONAL INSTITUTES OF HEALTH MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENTMaterials Cooperative Research and Development Agreement • June 7th, 2016
This Materials Cooperative Research and Development Agreement (“M-CRADA”) has been adopted for use by the Institutes and Centers (“ICs”) of the National Institutes of Health (“NIH”) for transfers of essential research material(s) from collaborators (hereinafter “Collaborator Research Material”) not otherwise reasonably available for NIH research. It consists of a copy of the NIH Model M-CRADA, a Signature Page, a Contacts Page, and a Summary Page. The research plan (“Research Plan”) is attached as Appendix A and all changes to this model agreement are collected in Appendix B. Appendices A and B are incorporated herein by reference. This M-CRADA involves no exchange of personnel or of any resources other than as described in Appendix A. This M-CRADA is made under authority of the Federal Technology Transfer Act, 15 U.S.C. § 3710a, and is governed by its terms.
EXHIBIT 10.12 NATIONAL INSTITUTES OF HEALTH MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT This Materials Cooperative Research and Development Agreement ("Materials CRADA") has been adopted for use of the National Institutes of Health...Materials Cooperative Research and Development Agreement • July 24th, 2000 • Keryx Biophamaeuticals Inc • Services-commercial physical & biological research
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENTMaterials Cooperative Research and Development Agreement • May 1st, 2023 • District of Columbia
This Materials Cooperative Research and Development Agreement (“Materials CRADA” or “Agreement”) is entered into by and between DNTOX GmbH (“DNTOX” or “Collaborator”), a German company with a principal place of business at Gurlittstraße 53, D-40223 Düsseldorf, Germany, and the United States Environmental Protection Agency (“EPA”) Center for Computational Toxicology and Exposure (CCTE), under the authority of Title 15, United States Code §§ 3710a-3710d (commonly known as the Federal Technology Transfer Act of 1986).
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT (MCRADA)Materials Cooperative Research and Development Agreement • July 9th, 2024 • District of Columbia
of the U.S. Environmental Protection Agency (“EPA”) under the authority of Title 15, United States Code §§ 3710a-3710d (commonly known as the Federal Technology Transfer Act of 1986).
NATIONAL INSTITUTES OF HEALTH MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENTMaterials Cooperative Research and Development Agreement • March 21st, 2014 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations
This Materials Cooperative Research and Development Agreement (“M-CRADA”) has been adopted for use by the Institutes and Centers (“ICs”) of the National Institutes of Health (“NIH”) for transfers of essential research material(s) from collaborators (hereinafter “Collaborator Research Material”) not otherwise reasonably available for NIH research. It consists of a copy of the NIH Model M-CRADA, a Signature Page, a Contacts Page, and a Summary Page. The research plan (“Research Plan”) is attached as Appendix A and all changes to this model agreement are collected in Appendix B. Appendices A and B are incorporated herein by reference. This M-CRADA involves no exchange of personnel or of any resources other than as described in Appendix A. This M-CRADA is made under authority of the Federal Technology Transfer Act, 15 U.S.C. § 3710a, and is governed by its terms.
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT (MCRADA)Materials Cooperative Research and Development Agreement • March 5th, 2024 • District of Columbia
of the U.S. Environmental Protection Agency (“EPA”) under the authority of Title 15, United States Code §§ 3710a-3710d (commonly known as the Federal Technology Transfer Act of 1986).
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENTMaterials Cooperative Research and Development Agreement • March 11th, 2024
This Materials Cooperative Research and Development Agreement (“Materials CRADA” or “Agreement”) is entered into by and between European Commission Joint Research Centre (JRC) Directorate F – Health and Food Unit F.3 – Systems Toxicology, incorporating the EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) which has its principal place of business at Via E. Fermi 2749, Ispra, Italy (the Collaborator), and the United States Environmental Protection Agency (“EPA”) Center for Computational Toxicology and Exposure (CCTE), under the authority of Title 15, United States Code §§ 3710a-3710d (commonly known as the Federal Technology Transfer Act of 1986).
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT WITH THEMaterials Cooperative Research and Development Agreement • September 20th, 2022
This Materials Cooperative Research and Development Agreement (“MCRADA” or “Agreement”) is entered into by and between Lexogen GmbH, which has its principal place of business at Campus Vienna Biocenter 5, 1030 Vienna, Austria (“the Collaborator”), and the Center for Computational Toxicology and Exposure (“the Center”), of the U.S. Environmental Protection Agency (“EPA”) under the authority of Title 15, United States Code §§ 3710a-3710d (commonly known as the Federal Technology Transfer Act of 1986).
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT (MCRADA)Materials Cooperative Research and Development Agreement • October 26th, 2020
This Materials Cooperative Research and Development Agreement (“MCRADA” or "Agreement") is entered into by and between XYZ Foods, Inc. an Arkansas Corporation which has its principal place of business at 123 Corporation Road, Little Rock, AR 72002 ("the Cooperator"), and the National Exposure Research Laboratory (NERL) 26 West Martin Luther King Drive, Cincinnati, OH 45268 ("the Laboratory"), of the U.S. Environmental Protection Agency ("EPA") under the authority of Title 15, United States Code §§ 3710a-3710d (commonly known as the Federal Technology Transfer Act of 1986).
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT (MCRADA)Materials Cooperative Research and Development Agreement • March 1st, 2024 • District of Columbia
This Materials Cooperative Research and Development Agreement (“MCRADA” or “Agreement”) is entered into by and between Syngenta Crop Protection, LLC, a Delaware Corporation which has its principal place of business at 410 Swing Road S, Greensboro, NC 27409 (“the Collaborator”), and the Center for Computational Toxicology and Exposure (“CCTE” or “Center”), of the U.S. Environmental Protection Agency (“EPA”) under the authority of Title 15, United States Code §§ 3710a-3710d (commonly known as the Federal Technology Transfer Act of 1986).
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT (MCRADA)Materials Cooperative Research and Development Agreement • February 6th, 2024 • District of Columbia
This Materials Cooperative Research and Development Agreement (“MCRADA” or “Agreement”) is entered into by and between [COOPERATOR NAME], a [BUSINESS/ORGANIZATION TYPE] which has its principal place of business at [ADDRESS] (“the Collaborator”), and the [CENTER NAME] (“[CENTER INITIALS]” or “the Center”), of the U.S. Environmental Protection Agency (“EPA”) under the authority of Title 15, United States Code §§ 3710a-3710d (commonly known as the Federal Technology Transfer Act of 1986).
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT (MCRADA)Materials Cooperative Research and Development Agreement • May 13th, 2022
This Materials Cooperative Research and Development Agreement (“MCRADA” or "Agreement") is entered into by and between [insert business name] a [name the state in which the Collaborator is incorporated] Corporation which has its principal place of business at ("the Collaborator"), and the____________ [the EPA Center or Office] ("the Center"), of the U.S. Environmental Protection Agency ("EPA") under the authority of Title 15, United States Code 3710a-3710d (commonly known as the Federal Technology Transfer Act of 1986).
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT (MCRADA)Materials Cooperative Research and Development Agreement • February 3rd, 2023
This Materials Cooperative Research and Development Agreement (“Materials CRADA”) has been adopted for use by the Environmental Protection Agency (“EPA”) for collaborations that will not exceed two years in term; will involve transfers of essential material (“Research Material”), but no other resources; and are unlikely to result in new intellectual property. Typical applications include short-term studies to: 1) test new reagents or research tools when such assessments require collaboration between provider and recipient institutions or 2) determine the feasibility, optimal study design, and/or resource requirements for a long-term study between the collaborating institutions. Collaborative research and development studies not meeting these criteria must be submitted for approval using the standard CRADA agreement.
MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENTMaterials Cooperative Research and Development Agreement • February 3rd, 2000
This Materials Cooperative Research and Development Agreement ("Materials CRADA") has been adopted for use by the National Institutes of Health ("NIH") for transfers of essential research material ("Research Material") not otherwise reasonably available for NIH research.
